As next-generation DNA sequencing technology continues to evolve and become further integrated into routine clinical testing, the need for efficient and accurate clinical interpretation of oncology diagnostic tests becomes even more pressing—especially among community hospital labs.

Standard sequencing panels are growing, drugs are covering more targets and pathways, and the expansion of the scientific and clinical literature has become exponential, presenting a significant challenge to laboratory directors and clinicians who need to understand the implications of the test results. Further, the implications of mutations can be applicable across many cancer types, but often are different based on the specific cancer type.

In this webinar, we will discuss how community hospital labs can perform comprehensive genomic profiling faster and with greater accuracy and confidence using QIAGEN’s professional clinical interpretation services: QCI Precision Insights.

Attendees will learn:

About the world-class team of molecular biologists and oncologists that power QCI Precision Insights
How community hospital labs can get up-to-date and detailed disease-specific clinical insights and therapeutic options for each patient within minutes
About use-cases and examples of clinical annotation in different diseases of varying specificity

Speakers
Sheryl Elkin, PhD
Chief Scientific Officer
N-of-One, a QIAGEN company

Linda Call, Ph.D.
Director of Scientific and Clinical Operations
QIAGEN Digital Insights